 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
New Firm MetaDiagnostic Moves in to Help Dx Developers, Payors as PBMs Shift from Personalized Rx
August 29, 2012
New Firm MetaDiagnostic Moves in to Help Dx Developers, Payors as PBMs Shift from Personalized Rx
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Buying Remaining Stake in Generation Health, CVS Caremark Keeps PGx Programs but Cuts Staff
August 29, 2012 / Pharmacogenomics Reporter - Personalized Medicine in 2012: Industry Takes a Wait-and-See Approach Due to Market Unknowns
January 9, 2013 / Pharmacogenomics Reporter - Fate of Medco's Personalized Medicine Programs Uncertain Under Express Scripts' Acquisition Plan
July 27, 2011 / Pharmacogenomics Reporter - Generation Health Tackles Slow Genetic Test Uptake by Unpacking CPT Codes, Planning Utility Studies
May 11, 2011 / Pharmacogenomics Reporter - CVS Caremark, Generation Health Unveil 13 Drugs for PGx Testing Program, But Not Warfarin
June 2, 2010 / Pharmacogenomics Reporter